Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of July 24, 2025 • 9:01 PM ET

Date/Time Source News Release
07/25/2022 07:00 AM EDT GlobeNewswire Pluri CEO Issues Shareholder Update
07/25/2022 01:00 AM EDT GlobeNewswire Pluristem Therapeutics Inc. Changes its Name to "Pluri Inc." Reflecting the Company's Strategy to Leverage its Innovative 3D Cell-based Technology Platform to Additional Industries
07/13/2022 06:00 AM EDT GlobeNewswire Pluristem Reports Topline Results from its Phase III Study of Muscle Regeneration Following Hip Fracture Surgery
03/28/2022 03:00 AM EDT GlobeNewswire Pluristem and Tnuva to Ring Nasdaq Closing Bell in Honor of New Partnership
03/23/2022 07:30 AM EDT GlobeNewswire Pluristem Releases PLX-R18 Hematology Phase I Study Results: Data Show Increase in All Blood Lines and Reduction in Blood Transfusions
03/08/2022 07:12 AM EST GlobeNewswire Pluristem and Tnuva Appoint Food Tech Veteran Eyal Rosenthal as Chief Executive Officer of their New Joint Venture
03/02/2022 07:00 AM EST GlobeNewswire Pluristem CEO Issues Shareholder Update
02/24/2022 07:00 AM EST GlobeNewswire Pluristem Announce the Closing of its Collaboration with Tnuva Group to Establish Cultured Food Platform
01/10/2022 03:00 AM EST GlobeNewswire Biotechnology Company Pluristem, and Israel's Largest Food Producer Tnuva, Launch Landmark Collaboration to Establish Cultured Food Platform
12/27/2021 07:00 AM EST GlobeNewswire Pluristem Reports Topline Results from its Phase II Studies of Acute Respiratory Distress Syndrome Associated with COVID-19
Page

Additional News

As of July 24, 2025 • 9:01 PM ET

Date/Time Source News Release
07/25/2022 05:55 AM EDT SeekingAlpha Pluristem Therapeutics renames as Pluri
07/14/2022 11:15 AM EDT Zacks Pluristem (PSTI) Phase III Study Misses Goal, Stock Down
07/13/2022 07:08 AM EDT SeekingAlpha Pluristem says Phase 3 trial for muscle injury therapy did not meet key goal
03/23/2022 11:59 AM EDT SeekingAlpha Pluristem PLX-R18 shows promise in blood cell recovery in cell transplant patients in trial
01/22/2022 11:30 AM EST PennyStocks.com Best Penny Stocks to Buy as January Ends? 4 to Watch
01/18/2022 07:38 AM EST InvestorPlace Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
01/10/2022 10:38 AM EST PennyStocks.com Best Penny Stocks to Buy Right Now? 3 For Your List in January
12/29/2021 11:00 AM EST Zacks Kiniksa (KNSA) COVID-19 Study for ARDS Fails to Meet Main Goal
12/28/2021 12:04 PM EST Zacks Pluristem (PSTI) Misses Study Goal to Treat COVID-Related ARDS
12/27/2021 01:01 PM EST SeekingAlpha PYR, SPRB and BBIO among mid-day movers
Page